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INTRODUCTION
============

The mechanisms that regulate the removal of salt and water from the distal airspaces of the lung are relevant to understanding the resolution of clinical pulmonary edema. Most experimental studies have attributed a primary role for active sodium transport in the vectorial transport of salt and water from the apical to the basal surface of the alveolar epithelium. Several in vivo studies have demonstrated that inhibition of sodium uptake by amiloride, or one of its analogues, reduces the rate of vectorial salt and water transport in the sheep, rat, rabbit, mouse, and human lung ([@bib4]; [@bib15]; [@bib31]). In vitro studies support a role for sodium in driving salt transport across cultured alveolar epithelial type II cells ([@bib10]; [@bib30]; [@bib21]). Also, the α subunit of the apical epithelial sodium channel (ENaC)[\*](#fn1){ref-type="fn"} is essential for the perinatal removal of alveolar fluid in the mouse lung ([@bib20]).

The contribution of chloride transport to the isosmolar reabsorption of fluid from the distal airspaces of the lung is less clear. Measurements on cultured alveolar epithelial type II cells suggested that cAMP mediated apical uptake of sodium may be driven by an increase in chloride conductance ([@bib22]). However, the results were considered inconclusive, partly because the experiments were done using cultured alveolar epithelial cells of uncertain phenotype ([@bib27]; [@bib45]). Furthermore, studies of isolated alveolar epithelial type II cells do not address the possibility that vectorial fluid transport may be mediated by several different epithelial cell types including alveolar epithelial type I cells ([@bib5]; [@bib24]) as well as distal airway epithelial cells ([@bib17]). Studies in several species have indicated that the distal airway epithelium is capable of ion transport ([@bib3]; [@bib1]). Both ENaC and the CFTR are expressed in distal airway as well as alveolar epithelia ([@bib16]; [@bib35]).

We reasoned that intact lung studies were required to define the role of chloride and CFTR in active salt and water transport across the distal airspaces. Several strategies were used. Inhibition and ion substitution experiments indicated an important role for transcellular chloride transport. Experiments in wild-type mice and the ex vivo human lung demonstrated that isoproterenol-stimulated fluid absorption was inhibited by glibenclamide, suggesting a role for CFTR. To test the role of CFTR directly, cystic fibrosis mice (ΔF508) were studied. Both fluid absorption and ^36^Cl uptake from the distal airspaces were stimulated by isoproterenol in wild-type, but not in ΔF508 mice. Finally, the significance of the impaired fluid transport in ΔF508 mice was tested in a model of acute hydrostatic pulmonary edema. The impaired fluid clearance in ΔF508 mice resulted in high lung water and alveolar edema. These studies provide the first direct evidence for a major function of CFTR in the distal epithelium of the lung.

MATERIALS AND METHODS
=====================

Transgenic Mice
---------------

ΔF508 mice on a C57BL6/J-C3H/HeJ hybrid genetic background were provided by the CFRDP animal core at the University of California, San Francisco. Heterozygous offspring, which appeared phenotypically normal, were intercrossed to generate homozygous mutant ΔF508 mice. Genotype analysis of tail DNA was done by PCR at 10 d of age. The wild-type and heterozygous mice were fed a standard diet and the ΔF508 mice a liquid diet as recommended ([@bib26]). The ΔF508 mice show pathological and electrophysiological changes consistent with a CF phenotype ([@bib12]). Measurements were done in litter-matched mice (8--12 wk of age). The investigators were blinded to genotype information for all comparative transport measurements. Protocols were approved by the University of California at San Francisco Committee on Animal Research.

Measurements of Fluid Clearance in Mice
---------------------------------------

Mice were killed using intraperitoneal pentobarbital (200 mg/kg). A tracheostomy was rapidly done with a 20-gauge angiocatheter. Lungs were inflated with 100% oxygen at 4 cm H~2~O continuous positive airway pressure throughout the experiment. In these in situ experiments, body temperature was maintained at 37--38°C using an infrared lamp and intra-abdominal monitoring thermister. In in situ perfused experiments, the pulmonary artery was cannulated with polyethylene PE-20 tubing and the left atrium was transected to permit fluid exit. The pulmonary artery was gravity perfused at 5 cm H~2~O pressure, and the perfusate was maintained at 37°C as described previously ([@bib2]; [@bib29]).

To measure fluid clearance from the distal airspaces, 10 ml/kg of instillate was delivered to both lungs over 30 s through the tracheal cannula. The instillate consisted of Ringer\'s lactate (\[in mM\] 102.6 NaCl, 4.02 KCl, 1.36 CaCl~2~, and 28 sodium lactate) containing 5% BSA and \[^131^I\]albumin (0.1 μCi) adjusted to 325 mOsm with NaCl and pH 7.4 to match the mouse serum osmolarity. At the end of the experimental time period, a fluid sample (50--100 μl) was aspirated with a 1-ml syringe connected directly into the catheter. The aspirate was weighed and assayed for ^131^I radioactivity. The percent fluid absorption at 15 min was computed from the ratio of instillate and aspirate radioactivities as described previously ([@bib19]; [@bib29]).

For the ion substitution experiments, perfusion was started 10 min before the airspace solution was instilled. The perfusate was identical to the instillate except for the absence of the volume marker \[^131^I\]albumin. In some studies, 1 mM amiloride, 0.1 mM NPPB, 0.1 mM ouabain, 0.1 mM glibenclamide, 0.1 mM isoproterenol, or 0.1 mM each of forskolin + IBMX was added to the instillate. The ion substitution solution was as follows: "100% NaCl" (\[in mM\] 162 NaCl, 0.9 CaCl~2~, and 1.5 KH~2~PO~4~), "50% Na^+^/choline^+^" (\[in mM\] 81 NaCl, 81 choline Cl, 0.9 CaCl~2~, 1.5 KH~2~PO~4~), "50% Cl^−^/NO~3~" (\[in mM\] 81 NaCl, 81 NaNO~3~, 0.9 CaCl~2~, and 1.5 KH~2~PO~4~), and "50% Cl^−^/gluconate^−^" (\[in mM\] 81 NaCl, 81 sodium gluconate, 0.9 mM CaCl~2~, and 1.5 KH~2~PO~4~). All solutions were adjusted to 325 mOsm and pH 7.4.

Measurement of Fluid Clearance in Human Lung
--------------------------------------------

The ex vivo human lung study was done with the approval of Human Research Committee at UCSF. Human lungs were obtained from 42 human lung donors whose lungs were rejected for transplantation. As previously described ([@bib36], [@bib37]), a segmental bronchus was occluded by a balloon catheter. Through the catheter, the lung was inflated with 8 cm H~2~O airway pressure with 100% oxygen and placed in a plastic bag and a humidified incubator at 37°C for 3--4 h to warm the lung. Next, 60--120 ml of isosmolar 5% human albumin solution containing 5 μCi \[^131^I\]albumin warmed at 37°C was instilled into the occluded segment followed by 40 ml of air to advance the instilled albumin solution into the distal airspaces. 1 h after instillation, alveolar fluid was aspirated. The aspirate sample was assayed for ^131^I radioactivity and fluid absorption calculated. In some experiments, 0.1 mM terbutaline and/or 0.1 mM glibenclamide were added to the instillate.

Uptake of ^22^Na and ^36^Cl in the Mouse Lung
---------------------------------------------

These studies were done in the in situ perfused mouse lung at room temperature (23°C). Identical solutions (102.6 mM NaCl, 4.02 mM KCl, 1.36 mM CaCl~2~, 28 mM sodium lactate, 5% albumin, and 325 mOsm, pH 7.4) were used in the perfusate and instillate, except for the presence of tracer quantities of ^22^Na and ^36^Cl in the airspace instillate. ^22^Na was measured using a γ counter, and ^36^Cl by a scintillation counter (with correction for ^22^Na counts). A sample of the instilled fluid was obtained at 1 and 30 min (1 min was taken as 0 point because the instillate may be diluted initially). In some experiments, 0.1 mM isoproterenol and/or 0.1 mM glibenclamide was added to the instillate and perfusate. Albumin concentrations were measured at 1 and 30 min to confirm that there was no net fluid clearance from the airspaces of the lung, as we and others have reported previously that room temperature abolishes active fluid clearance ([@bib31]). In some experiments \[^14^C\]mannitol was instilled as a paracellular permeability marker.

Hydrostatic Volume-overload Studies in Mice
-------------------------------------------

A standard model of acute hydrostatic edema was used ([@bib7]; [@bib18]). Mice were anesthetized (ketamine 80 mg/kg and xylazine 12 mg/kg) and ventilated with a constant volume ventilator (Harvard Apparatus) with a tidal volume of 8 ml/kg, a positive end--expiratory pressure of 3 cm H~2~O, and 100% oxygen. A catheter was inserted into the left carotid artery to obtain blood samples and infuse fluid. The respiratory rate was adjusted to maintain the PaCO~2~ at 30--40 mmHg. The mice were monitored by electrocardiography. After a 20-min baseline period, an intra-arterial infusion of saline was given by an infusion pump over 2 h (total volume = 40% of body weight, with 40% of the total volume given over the first 20 min, the remaining 60% volume administered over 100 min). In some experiments, propranolol was given at escalating dose (5--21 μg/kg/min) before volume overload. At 2 h, the mice were killed by exsanguination, a blood sample was obtained for measurement of hemoglobin concentration and the wet-to-dry weight ratio of blood. The lungs were removed and homogenized for measurement of the wet-to-dry weight ratio using standard methods ([@bib4]; [@bib19]). Histopathology was done as previously described ([@bib25]): lungs were inflated to total lung capacity, and the tracheas were ligated. Lungs were placed in 300 ml PBS heated to 60°C for 3 min in a microwave oven and transferred to 4% paraformaldehyde overnight. The lungs were embedded with paraffin and sections were cut at 4-μm thickness stained with hematoxylin and eosin.

Statistics
----------

Data are summarized as mean ± SEM. Analysis of variance was used to compare the different animal groups. Where appropriate, an unpaired *t* test was used*. P* \< 0.05 was taken as statistically significant.

RESULTS
=======

Role of Transcellular Sodium and Chloride Transport
---------------------------------------------------

Isosmolar fluid absorption, measured initially in the in situ nonperfused mouse lung, was reduced by 70--80% with amiloride or NPPB ([Fig. 1](#fig1){ref-type="fig"}), indicating that inhibition of sodium or chloride transport can prevent basal vectorial fluid transport across the distal pulmonary epithelium. These results provide evidence that transcellular fluid transport probably occurs for both sodium and chloride. As expected, inhibition of Na^+^/K^+^-ATPase by ouabain markedly inhibited fluid absorption.

![Effect of amiloride, NPPB, and ouabain on isosmolar fluid clearance at 37°C in the in situ nonperfused lung of wild-type mice. Fluid clearance is expressed as the percent fluid absorption at 15 min (*n* = 6--8 mice in each group). Where indicated, the instillate contained 1 mM amiloride, 0.1 mM NPPB, or 0.1 mM ouabain. \**P* \< 0.05 compared with control, data as mean ± SEM.](8521f1){#fig1}

To assess qualitatively the relative contributions of sodium and chloride to fluid absorption, isosmolar ion substitution studies were performed in the in situ perfused mouse lung. In the in situ perfused model, the basal fluid clearance rates are ∼50% of those in the nonperfused in situ lung ([@bib29]). The same concentration of solutes on both sides of the distal pulmonary epithelium was achieved by using the same solution for both the perfusate and the instillate in the airspaces. This approach avoids the problem of solute imbalance that can occur with ion substitution experiments that change solute concentrations on only one side of the transporting epithelium. A reduction in \[Na^+^\] to 50% by the substitution of choline^+^ had little effect on basal fluid clearance ([Fig. 2](#fig2){ref-type="fig"}, open bars). However, reduction in \[Cl^−^\] to 50% by the substitution of gluconate^-^ inhibited distal airspace fluid clearance by ∼50%. Reduction in the concentration of \[Cl^−^\] to 50% by substitution of nitrate^−^, an anion that can generally substitute for Cl^−^ in Cl^−^ channels, had no effect on basal fluid clearance. Also, fluid absorption after cAMP agonists was significantly lower with a 50% reduction of \[Cl^−^\] than with a 50% reduction of \[Na^+^\] ([Fig. 2](#fig2){ref-type="fig"}, closed bars).

![Effect of ion substitution on isosmolar fluid clearance from the distal airspaces. Experiments were done in the in situ perfused lung at 37°C in wild-type mice. The x-axis indicates the composition of the test solutions. Measurements were done under basal (open bars, *n* = 6 mice in each group) and isoproterenol stimulated (closed bars, *n* = 6 in each group) conditions. \**P* \< 0.05 compared with all other control conditions; \*\**P* \< 0.05 compared with basal in each group, data as mean ± SEM.](8521f2){#fig2}

The results suggest that chloride can be rate limiting in isosmolar fluid transport under both basal and isoproterenol-stimulated conditions. However, substitution of Cl^−^ for gluconate^−^ may depolarize the apical membrane potential and could reduce the driving force for Na^+^ transport. Alternatively, the low free--ionized calcium in the gluconate solutions may reduce possible calcium-dependent chloride permeability. Therefore, the results of these studies provided suggestive, but not conclusive, evidence for a role of chloride in transcellular epithelial transport. Additional experiments were performed to assess the role of chloride transport by CFTR, using both pharmacologic inhibition of CFTR and cystic fibrosis mice.

Role of CFTR in cAMP-stimulated Fluid Absorption
------------------------------------------------

Two strategies were used to test the potential role of CFTR in fluid absorption in the distal airspaces of the lung. The first approach was to inhibit chloride transport with glibenclamide, a relatively selective inhibitor of CFTR ([@bib39]). The second approach was to measure fluid absorption in ΔF508 mice that lack functional CFTR in the cell plasma membrane ([@bib11]). Studies were done under both basal- and cAMP-stimulated conditions.

The initial experiments showed that glibenclamide had no effect on basal clearance ([Fig. 3](#fig3){ref-type="fig"} A). Isoproterenol stimulated basal fluid clearance, as previously reported ([@bib2]; [@bib19]), but glibenclamide prevented the cAMP-induced increase in fluid clearance ([Fig. 3](#fig3){ref-type="fig"} A). These results provided support for the hypothesis that CFTR may mediate the cAMP stimulated increase in fluid clearance.

![Effect of glibenclamide on fluid clearance in mouse and human lung. (A) Fluid clearance in the in situ perfused lung of wild-type mice at 37°C*.* Fluid clearance is expressed as the percent absorption at 15 min under control conditions (*n* = 12), glibenclamide (0.1 mM, *n* = 6), isoproterenol (0.1 mM, *n* = 18), and isoproterenol + glibenclamide (*n* = 6). \**P* \< 0.05 compared with control, data as mean ± SEM. (B) Measurements of fluid clearance in rewarmed ex vivo human lung at 37°C. Fluid clearance is expressed as the percent absorption at 1 h under control conditions (*n* = 23), glibenclamide (0.1 mM, *n* = 5), terbutaline (0.1 mM, *n* = 8), and terbutaline + glibenclamide (*n* = 6). \**P* \< 0.05 compared with control, data as mean ± SEM.](8521f3){#fig3}

To determine if CFTR inhibition by glibenclamide would also impair cAMP-stimulated clearance in the human lung, an ex vivo human lung preparation was used ([@bib38]). Glibenclamide alone had no effect on basal fluid clearance in the ex vivo human lung ([Fig. 3](#fig3){ref-type="fig"} B). cAMP stimulation with terbutaline increased fluid clearance. cAMP-stimulated fluid clearance was prevented by glibenclamide, which is similar to the studies in the mouse lung.

To directly test the role of CFTR in isosmolar fluid clearance in the in situ mouse lung, we used cystic fibrosis mice. Studies of fluid absorption in wild-type and ΔF508 mice showed no difference in basal isosmolar fluid clearance ([Fig. 4](#fig4){ref-type="fig"}, open bars), which is consistent with the observation that glibenclamide did not impair basal clearance in the human or mouse lung. In the presence of isoproterenol, fluid clearance was markedly increased in the wild-type mice but not changed in the ΔF508 mice ([Fig. 4](#fig4){ref-type="fig"}, closed bars). To be certain that the lack of response to isoproterenol was not due to downregulation of β receptors, additional studies were done with forskolin/IBMX (0.1 mM each, *n* = 10 wild-type and 6 ΔF508 mice). There was a 57 ± 7% increase in fluid clearance in the wild-type mice, but no change in fluid clearance in the ΔF508 mice. The data support the conclusion that CFTR is required for cAMP-mediated upregulation of fluid clearance, but is not necessary for basal fluid absorption.

![Fluid clearance from the distal airspaces of wild-type (open bars) and ΔF508 (closed bars) mice. Measurements were done in the in situ perfused lung at 37°C under basal conditions (*n* = 24 wild-type, *n* = 7 ΔF508) and in the presence of 0.1 mM isoproterenol (*n* = 9 wild-type, *n* = 6 ΔF508). \**P* \< 0.05 compared with control group, data as mean ± SEM.](8521f4){#fig4}

^22^Na and ^36^Cl Uptake in Mouse Lung under Isotopic Conditions
----------------------------------------------------------------

Active transport across the distal lung epithelium at 37°C couples salt (sodium and chloride) and water to maintain isosmolar conditions ([@bib40]). Thus, it is not possible to study the separate transport of sodium and chloride. Experiments were designed to measure the passive transport of tracer ^22^Na and ^36^Cl in in situ perfused mouse lungs at room temperature (23°C). Since room temperature abolishes active ion transport, isotopic transport of ^22^Na and ^36^Cl from the distal airspaces of the lung occurs without a change in the net air space fluid volume, and can occur by an exchange mechanism without obligate counterion cotransport. Measurement of alveolar protein concentration confirmed there was no net clearance of distal airspace fluid during these experiments, since the concentration of albumin was the same at 1 and 30 min after instillation. Under basal conditions, ^22^Na and ^36^Cl loss from the air spaces was similar, ∼20% in 30 min ([Fig. 5](#fig5){ref-type="fig"}). In the presence of isoproterenol, ^36^Cl removal was accelerated significantly, whereas ^22^Na removal was not changed. The isoproterenol-induced increase in ^36^Cl transport was inhibited by glibenclamide, providing evidence that the cAMP stimulated uptake of ^36^Cl under isotopic conditions may be mediated by CFTR.

![Isotopic ^22^Na and ^36^Cl transport from the airspace compartment of wild-type and ΔF508 mice. Measurements were done in the in situ perfused lung preparation at 23°C. The y*-*axis is the ratio of final (30 min after instillation) to initial (1 min after instillation) ^22^Na or ^36^Cl radioactivities in fluid sampled from the distal airspaces. Individual (closed circles) and averaged (mean ± SEM) values are shown. Where indicated, the instillate contained 0.1 mM isoproterenol (iso), 0.1 mM glibenclamide (glib), and 0.1 mM isoproterenol + 0.1 mM glibenclamide. \**P* \< 0.05 compared with all other groups.](8521f5){#fig5}

To determine the contribution of CFTR in mediating cAMP-induced ^36^Cl transport from the distal air spaces, similar studies were performed in ΔF508 mice. The loss of ^22^Na and ^36^Cl in ΔF508 mice was not affected by isoproterenol ([Fig. 5](#fig5){ref-type="fig"}). These results provide direct evidence for a role of CFTR in cAMP-stimulated Cl^−^ transport in the distal airway epithelium. \[^14^C\]mannitol loss from the airspaces was the same under basal conditions and with isoproterenol stimulation, thus excluding an effect of cAMP agonists stimulation on paracellular epithelial permeability.

Hydrostatic Volume-overload Model of Pulmonary Edema
----------------------------------------------------

The previous experiments established a role for CFTR in cAMP stimulated fluid clearance from the distal airspaces of the lung. The final set of experiments were designed to test the contribution of CFTR to fluid clearance using a model of hydrostatic volume overload. Previous studies established that endogenous release of epinephrine stimulates fluid clearance from the airspaces of the lung during a hydrostatic stress ([@bib8]). These experiments were done to test the hypothesis that the lack of functional CFTR in ΔF508 mice would limit their capacity to remove alveolar edema.

Hydrostatic pulmonary edema was induced in ventilated mice using a standard preparation of acute intravascular volume expansion. After volume overload by saline infusion, there was 27% and 31% increase in the lung wet-to-dry weight ratio in wild-type and heterozygous mice, respectively ([Fig. 6](#fig6){ref-type="fig"}). In the ΔF508 mice, the lung wet-to-dry weight ratio increased by 64% (*P* \< 0.05). Lung histology showed moderate interstitial edema with perivascular fluid cuffs in wild-type mice without alveolar flooding, but marked alveolar edema was present in ΔF508 mice ([Fig. 6](#fig6){ref-type="fig"}, insets).

![Effect of acute volume overload on the lung wet-to-dry weight ratio in wild-type, heterozygous, and ΔF508 mice. 40% of body weight fluid was infused over 2 h ([materials]{.smallcaps} [and]{.smallcaps} [methods]{.smallcaps}). The y-axis is the lung wet-to-dry weight ratio. Individual (closed) and averaged (mean ± SEM) values are shown for indicated genotypes of mice. In the volume-overload group, where indicated, measurements were performed with and without propranolol (0.1 mM) pretreatment. (\**P* \< 0.05 compared with basal control; \*\**P* \< 0.05 compared with wild-type and heterozygous mice in the same group. \[Insets\] Micrographs show typical lung histopathology from three different groups, as indicated with the dashed lines). Normal distal airway and alveolar structure in control ventilated wild-type mice not subjected to volume overload (left). Thickening of interstitial space and perivascular fluid cuffs (arrow) in volume-overloaded wild-type mice (middle). Alveolar edema in most sections of volume-overloaded ΔF508 mice (right). Bar, 30 μm.](8521f6){#fig6}

If the higher lung water and alveolar edema in the ΔF508 mice were explained by the inability of elevated endogenous catecholamines to stimulate cAMP-dependent fluid clearance from the distal airspaces in the ΔF508 mice, blockade of endogenous catecholamines in the wild-type and heterozygous mice should produce a similar increase in lung water. Therefore, the effect of the β antagonist propranolol was tested. Blockade of endogenous catecholamines with propranolol resulted in similar increases in lung wet-to-dry weight ratio in the wild--type and heterozygous mice to the level measured in the ΔF508 mice. Thus, the impaired capacity to remove edema fluid from the distal airspaces of the lung in ΔF508 mice resulted in a significant increase in extravascular lung water in the presence of hydrostatic pulmonary edema.

DISCUSSION
==========

These experiments provide new information regarding the role of chloride and CFTR in the isosmolar reabsorption of fluid from the distal airspaces of the lung. Pharmacologic, ion substitution, isotopic ion transport, and gene knockout experiments indicated that cAMP-dependent fluid absorption from the distal airspaces of the lung involves chloride transport by CFTR. A potential role for chloride in cAMP-mediated fluid transport has been suggested in studies of cultured alveolar type II cells ([@bib23]), but the lack of intact lung studies has made it difficult to evaluate the role of chloride under conditions that are germane to in vivo fluid absorption. There are several cell types that may participate in salt and water transport from the distal airspaces of the lung including alveolar type I cells ([@bib13]; [@bib14]; [@bib5]; [@bib24]), alveolar type II cells ([@bib30]), and distal airway epithelial cells ([@bib3]; [@bib1]). The primary goal for these studies was to test the role of chloride and CFTR in the intact lung where the normal in vivo tissue morphology and driving forces for ion and water transport are present. Experiments in the intact lung also made it possible to study the role of chloride transport and CFTR in the pathophysiology of pulmonary edema.

The majority of the studies reported here were done in the intact mouse lung, a species that has a maximal rate of alveolar fluid clearance ([@bib19]; [@bib29]) that is similar to the rate of maximal alveolar fluid clearance measured during the resolution of alveolar edema in the human lung in patients with pulmonary edema ([@bib42]; [@bib43]). Pharmacologic studies were also done in an ex vivo human lung to confirm the relevance of findings in the mouse to the human lung.

The studies with glibenclamide, an inhibitor of CFTR, provided pharmacologic evidence that CFTR may be important in cAMP-stimulated fluid absorption in mouse lung as well as in the human lung. Because of the imperfect specificity of glibenclamide ([@bib39]), experiments also were done in homozygous ΔF508 mutant mice. In contrast to wild-type mice, neither isoproterenol nor forskolin increased fluid absorption. Also, isoproterenol did not increase ^36^Cl uptake in the isotopic studies in the ΔF508 mice. Although CFTR is necessary for cAMP-unregulated fluid clearance, basal clearance did not depend on CFTR, as demonstrated by normal rates of fluid clearance and ^36^Cl uptake in the ΔF508 mice and the lack of effect of glibenclamide on basal fluid clearance in the human or mouse lung. These studies indicate that basal fluid clearance in the mouse is CFTR- independent while cAMP stimulated fluid transport is CFTR-dependent.

The involvement of chloride transport and CFTR in lung fluid absorption were tested using an established mouse model of acute hydrostatic pulmonary edema that is associated with an increase in endogenous catecholamine levels. An acute increase in endogenous catecholamines is normally associated with a compensatory increase in the rate of distal epithelial fluid clearance that can protect against alveolar edema and reduce the quantity of edema formation in the lung ([@bib32]). A hydrostatic stress with volume overload resulted in significantly more pulmonary edema ΔF508 mice than in wild-type ΔF508 heterozygous mice. Alveolar edema was detected only in the ΔF508 mice. To confirm that the wild-type and heterozygous mice were protected by upregulated cAMP-stimulated fluid transport, the effect of endogenous catecholamines was inhibited by β blockade, as reported previously ([@bib32], [@bib33]). β blockade produced similar degrees of pulmonary edema in wild-type and ΔF508 mice, supporting the conclusion that cAMP stimulated CFTR activity plays an important role in the clearance of edema fluid from the distal airspaces of the lung.

There are several implications of these experiments. Since basal alveolar fluid clearance is rapid in the mouse and the human lung, the lack of CFTR would not be expected to prevent the normal clearance of perinatal fluid at the time of birth. This conclusion fits well with the observation that the lack of CFTR does not increase the risk of acute respiratory failure at birth in humans with cystic fibrosis nor in ΔF508 mice. However, the lack of CFTR in the adult lung could impair clearance of fluid from the distal airspaces of the lung under some pathological conditions that may be relevant to human cystic fibrosis. The most common cause of acute respiratory failure in cystic fibrosis is advanced obstructive airway disease, which is often complicated by bacterial pneumonia ([@bib6]). We previously reported that the removal of excess fluid from the distal airspaces of the lung is an important protective mechanism in *P*. *aeruginosa* pneumonia in rats ([@bib34]), and cAMP fluid dependent clearance is important in minimizing alveolar edema in septic and hypovolemic shock ([@bib32], [@bib33]). In addition, in patients with pulmonary edema from several different etiologies, the inability to generate maximal alveolar fluid clearance is associated with a longer duration of mechanical ventilation and a higher mortality ([@bib43]).

Finally, although the functional importance of CFTR is well recognized in the pathophysiology of cystic fibrosis in the proximal airways of the lung, it has been proposed without direct evidence that CFTR may have important functional significance in the distal lung ([@bib6]). These studies provide the first evidence for a functional role of CFTR in the distal pulmonary epithelium. Because the alveolar epithelium comprises the vast majority of the surface area of the lung ([@bib44]), previous estimates have discounted a significant role for the distal airway epithelium in the reabsorption of pulmonary edema. However, the findings of these studies indicate that distal airway epithelium may play an important role, partly because the expression of CFTR is greater in distal airway epithelium than in the alveoli ([@bib16]; [@bib35]). Recent studies have shown that water channel AQP4 (expressed in airway, but not alveolar, epithelia) plays a small but significant role in osmotically driven lung fluid transport ([@bib41]). cAMP fluid transport through CFTR also may occur across the alveolar epithelium based on evidence of expression of CFTR and β receptors in type I and II alveolar epithelial cells ([@bib9]; [@bib16]; [@bib35]; [@bib28]). Thus, the resolution of airspace edema is likely to depend on vectorial salt and water transport at the level of both the distal airway and alveolar epithelium, although further studies are needed to define the exact contributions of alveolar versus distal airway epithelium to the removal of distal airspace edema fluid.
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*Abbreviation used in this paper:* ENaC, epithelial sodium channel.
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